BridgeBio to report third-quarter 2026 financial results
BBIO•BridgeBio Pharma will release third-quarter 2026 financial results and a business update after the market close on October 29, 2026, with a conference call at 4:30 p.m. ET.
BBIO•BridgeBio Pharma will release third-quarter 2026 financial results and a business update after the market close on October 29, 2026, with a conference call at 4:30 p.m. ET.
BridgeBio Pharma will release third-quarter 2026 financial results and a business update after the market close on October 29, 2026. A conference call covering the results and program updates is scheduled for 4:30 p.m. ET that day.
